Table 1.
Author, year, country | Study size (n; I = intervention, C = standard care) | Study design | Study population Follow‐up duration | Interventiona | Outcomes | ||
---|---|---|---|---|---|---|---|
Health care professional education | Other | Prescribing | Clinical | ||||
Educational interventions to manage pain mainly using opioid analgesics | |||||||
Taylor et al., 2015, Australia38 | 1317(I: 0 mo = 2323 mo = 2476 mo = 238C: 0 mo = 2013 mo = 1996 mo = 200) | Multicentre, cluster‐randomised, controlled intervention trial | ED6 mo | ‐ Multidisciplinary face‐to‐face education to reduce pain by increasing provision of adequate analgesia | ‐ Audit and feedback (daily) | No change in opioid analgesic use | ↑ Patient satisfaction with pain management (42.9–53.9%*) |
‐ Patient education | |||||||
↑ Patient education (80.5% vs 86.1%*) | |||||||
‐ Hard copy and email material | |||||||
‐ Multiple choice self‐assessment | |||||||
‐ Online module | |||||||
‐ Pain posters | |||||||
Morisson et al., 2009, USA20 | 217(I: 129C: 88) | Controlled prospective propensity score‐matched clinical trial | Surgical6 mo | ‐ Multidisciplinary face‐to‐face health professional education to improve pain management according to local guidelines | ‐ Protocols for analgesia, opioid tapering and treatment of opioid‐related adverse events | ↑ Regular opioid analgesic use (98.0 vs 48.0%*) | ↓ No or mild pain at rest (66.0 vs 51.0%*) and activity (52.0 vs 38.0%*) |
↑ Concurrent laxatives prescribed (92.0 vs 83.0%*) | No change in opioid‐related adverse effects | ||||||
‐ Audit and feedback (monthly) | |||||||
‐ NRS pain evaluation | |||||||
Bingle et al., 1991, USA21 | 296(I: 147C: 149) | Pre–post intervention study | Surgical 6 mo | ‐ Academic detailing education for physicians encouraging pethidine (meperidine) use | ↑ Adherence of pethidine prescriptions to appropriateness criteria (30.0 vs 43.0%*) | ||
‐ Pen and hard‐copy material (Handbook on the Rational Use of Medication for Pain by Gerald M. Aronoff and Wayne O. Evans; pethidine dose <75 mg and administration interval longer than 3‐hourly defined to be inadequate) | |||||||
Boothby et al., 2003, USA50 | (60I: 30C: 30) | Pre–post intervention study | All inpatient3 mo | ‐ Academic detailing education for physicians discouraging pethidine use | ‐ Opinion leader | ↓ Pethidine use by 29.5% (95% CI 1.97–2.88*) ↑ Pethidine switch to morphine or hydromorphone and nonopioid analgesicsIn 85.0% of orders. | ↓ Opioid‐related ADEs (53.0 vs 23.0%*) |
‐ Policy change to replace pethidine with alternative opioids | |||||||
‐ Hard copy pocket cards for physicians and pharmacists | |||||||
‐ VAS pain evaluation‐ Bulletin and table‐top card material | ‐ Removal of pethidine from | ||||||
PCA | |||||||
‐ Pharmacist medication review | |||||||
Neitzel et al., 1999, USA22 | 118 (I: 61 C: 57) | Pre–post intervention study | Surgical8 mo | ‐ Physician, pharmacist and nurse 8‐h face‐to‐face education to increase evidence‐based pain management (Pain Awareness: Provider Information, Patient Needs syllabus developed by Pain Guidelines Implementation Team 1996) including systematic pain assessment, opioid analgesia, care plan communication | ‐ Opinion leader | ↑ Hydromorphone use by 18.0% | No change in pain intensity↓ Pethidine use by 48.0%* No change in opioid‐related ADEs↓ Hospital LOS from 5.9 to 5.1 ds* |
‐ Patient education | |||||||
No change in morphine use | |||||||
‐ Hard‐copy material | |||||||
Shaw et al., 2003, Australia51 | 336(I: Pre = 46, Post = 128C: Pre = 116Post = 46) | Pre–post intervention study | All inpatients 6 mo | ‐ Academic detailing education for physicians to increase appropriate opioid prescribing | ↓ Prescription error rate for drugs of addiction (41.0 vs 24.0%*) | ||
‐ Hard copy (bookmark) material summarising prescribing guidelines | |||||||
VanGulik et al., 2010, Netherlands35 | 190 (I: 130 C: 60) | Pre–post intervention study | ICU 3 mo | ‐ Multidisciplinary face‐to‐face education to increase pain assessment (NRS) and treatment with opioid analgesics | ‐ CPOE | ↑ Morphine use (22.6 vs 29.3 mg/d*) | ↓ Pain intensity (OR 2.54, 95% CI 1.22–5.65*) |
No change in ICU LOS or MV time | |||||||
‐ Email and bulletin material | |||||||
Akce et al., 2014, USA52 | 150 (I: 75 C: 75) | Retrospective serial cross‐sectional study | All inpatients 12 mo | ‐ Physician face‐to‐face education through group discussion of opioid case scenarios | ‐ CPOE | No change in opioid use | No change in pain intensity |
‐ Hard copy pocket cards for physicians | |||||||
Educational interventions to manage pain mainly using nonopioid analgesics | |||||||
Titsworth et al., 2016, USA23 | 96 (I: 48 C: 48) | Prospective, interrupted time‐series trial | Surgical 10 mo | ‐ Physician and nurse face‐to‐face education to increase pain assessment and use of nonopioid analgesia (paracetamol, NSAIDs, ketamine, gabapentin) ‐ NRS pain documentation | ‐ Acute pain service support ‐ Clinical rounds ‐ OME calculation tool‐ Patient education‐ Analgesia protocol | No change in morphine use on first postoperative d↓ Morphine use (3rd postoperative d: 72.3 ± 70.7 vs 39.2 ± 36.5 mg/d ± SD*)↑ Paracetamol use (56.3 vs 75.0%*)↑ NSAID use (8.3% vs 31.3%*) ↑ Gabapentin use (12.5 vs 33.3%*) No change in hospital LOS | ↓ Pain intensity (NRS: 4.31 vs 2.94*) |
Benditz et al., 2016, Germany24 | 367 | Prospective cohort study | Surgical24 mo | ‐ Physician and nurse face‐to‐face education to reduce pain by using nonpharmacological methods, nonopioid and opioid analgesics (German Guidelines of Pain Management in Nursing)‐ NRS pain evaluation | ‐ Adverse drug event evaluation‐ Internal benchmarking ‐ Monthly audit and feedback‐ Patient education | ↓ Pain intensity by 24.4%*No change in opioid‐related ADEs of nausea, dizziness or tiredness | |
Auyong et al., 2015, USA25 | 252 (I: 126 C: 126) | Pre–post intervention study | Surgical 1 mo | ‐ Multidisciplinary face‐to‐face education regarding updated Enhanced Recovery After Orthopedic Surgery Pathway‐Electronic and hard‐copy material ‐ NRS pain evaluation | ‐ Multimodal analgesia protocol including regular oral paracetamol, NSAIDs and gabapentin and when‐required oxycodone.‐ Physical therapy‐ Patient education | ↓ Morphine use on postoperative d 1 (IV equivalent 32.0 vs 23.5 mg*) and d 2 (IV equivalent 23.3 vs 15.9 mg*) | ↓ Hospital LOS (76.6 vs 56.1 h*)↓ Opioid‐related nausea on postoperative d 1 (37.3 vs 25.4%*) |
Chan et al., 2018, Hong Kong26 | 642 (I: 332 C: 310) | Pre–post intervention study | Surgical 8 mo | ‐Physician and nurse face‐to‐face education to encourage safe opioid use, nonopioid analgesia and nurse education to improve PCA safety‐ NRS pain evaluation | ‐ Audit and feedback (every 6 mo)‐ Patient education | ↑ Morphine use (88.6 vs 99.3%*) ↑ Diclofenac use (1.0 vs 96.9%) | ↓ Pain intensity (VAS > 7; 55.5 vs 21.0%*)↑ Pruritus incidence (12.4 vs 26.5%*) |
Humphries et al., 1997, UK27 | 242 (I: 122 C: 120) | Pre–post intervention study | Surgical12 mo | ‐ Posters and hard‐copy material outlining opioid guidelines (Victoria Hospital Blackpool Acute Pain Service) for physician and nursing staff | ‐ Analgesia protocol | ↑ Adherence of opioid prescriptions to British National Formulary (41.0 vs 61.0%*) and acute pain service (16.0 vs 26.0%*) | |
Juhl et al., 1996, Denmark28 | 317 (I: 126 C: 191) | Pre–post intervention study | Surgical 12 mo | ‐ Physician and nurse face‐to‐face 1‐d compulsory education to encourage routine use of nonopioid analgesia‐ Bedside tuition continued until all nurses familiar with new procedures | ‐ Performance feedback ‐ Nurse‐administered morphine | ↑ Non‐opioid analgesic use (15.0 vs 94.0%*) | ↓ Pain intensity (93.0 vs 86.0*) |
Majumder et al., 2016, USA29 | 200 (I: 100 C: 100) | Pre–post intervention study | Surgical 3 mo | ‐ Physician face‐to‐face education to minimise the use of opioid analgesics and paralytic agents | ‐ Multimodal analgesia (IV hydromorphone, oxycodone, oral gabapentin, paracetamol, NSAIDs)‐ Patient education | ↑ Switch from IV to oral opioid analgesia (2.2 vs 3.6 d after opioid initiation*) | ↓ Hospital LOS (4.0 vs 6.1 d*)↓ Hospital 90‐d readmission (16.0 vs 4.0%*) |
Usichenko et al., 2012, Germany30 | 520 (I: 251 C: 269) | Pre–post intervention questionnaire study | Surgical 14 mo | ‐ Multidisciplinary face‐to‐face education to increase nonopioid analgesic use ‐ Procedure‐specific, multifaceted analgesia protocol (PROSPECT and German Society of Anaesthesiology and Intensive Care Guidelines)‐ NRS pain evaluation | ‐ 24 h acute pain service‐ Audit and feedback (every 6 mo)‐ ADE treatment protocol ‐ Patient education | ↓ Pain intensity by 25.0–30.0% on visual rating scale* ↓ Nausea incidence (40.0 vs 17.0%*)↓ Vomiting incidence (25.0 vs 11.0%*) ↓ Tiredness incidence (76.0 vs 30.0%*)↑ Patient satisfaction with pain treatment*↑ QOL* |
Sorted in descending order of intervention complexity, as assessed by the iCAT_SR Tool,19 and subclassified in descending order of study design.68
Denotes statistical significance (P < .05).
ED = emergency department; ICU = intensive care unit; VAS = visual analogue scale; NRS = numeric rating scale; CPOE = computerised physician order entry; PCA = patient controlled analgesia; NSAID = nonsteroidal anti‐inflammatory drug; LOS = length of stay; ADE = adverse drug event; MV = mechanical ventilation; OR = odds ratio; CI = confidence interval; OME = oral morphine equivalents; IQR = interquartile range; QOL = quality of life; IV = intravenous; PROSPECT = procedure specific postoperative pain management